Justia Business Law Opinion Summaries

Ashley Energy, an energy company in Missouri, experienced flooding at its plant and leased a boiler and water treatment trailer from Indeck Power Equipment to maintain operations. The lease required Indeck to provide a “like-new” boiler and new trailer, and Ashley to operate and maintain the equipment according to industry standards, specifically ABMA guidelines, and pay for repairs beyond ordinary wear and tear. After the boiler was returned, Indeck discovered scale and debris, attempted to clean it, and ultimately sued Ashley, alleging breach of contract and seeking over $3 million in damages. Ashley had previously sued Indeck in Missouri state court, but that case was dismissed due to a forum selection clause.The United States District Court for the Northern District of Illinois conducted a jury trial. The jury found that Indeck had performed its contractual obligations and that Ashley had breached the contract. However, the jury concluded that Indeck failed to prove it had sustained damages as a result of Ashley’s breach, finding insufficient evidence that Ashley’s actions directly caused damage beyond normal wear and tear. Indeck’s post-trial motions for a new trial and for attorneys’ and experts’ fees were denied, with the district court explaining that the verdict could be rationally explained by evidence that Indeck’s own actions or equipment contributed to any damage or that no damage beyond ordinary wear and tear occurred.On appeal, the United States Court of Appeals for the Seventh Circuit affirmed the district court’s judgment. The appellate court held that the jury’s verdict was not irreconcilably inconsistent and was supported by plausible explanations from the record, and that Indeck was not entitled to attorneys’ fees as a non-prevailing party under the lease’s provisions. View "Indeck Power Equipment Co. v Ashley Energy LLC" on Justia Law

In 2016, Venezuela’s state-owned oil company, PDVSA, initiated a bond exchange offer allowing holders of unsecured notes due in 2017 to swap them for new, secured notes due in 2020. As collateral, PDVSA pledged a controlling interest in CITGO Holding, Inc., a major U.S.-based subsidiary. About 39% of the 2017 noteholders participated. PDVSA defaulted on the 2020 notes in October 2019, raising the risk that creditors could seize the CITGO collateral. This took place during significant political upheaval in Venezuela, including disputes over the country’s legitimate government and control of PDVSA.The PDV Entities filed suit in the United States District Court for the Southern District of New York, seeking to declare the bond exchange and related agreements void and unenforceable. They argued that Venezuelan law, specifically Article 150 of the Venezuelan Constitution, required National Assembly approval for such a transaction, which was not obtained. They also asserted that resolutions from the Venezuelan National Assembly in 2016 and 2019 invalidated the transaction as acts of state. The district court initially ruled for Defendants, holding that New York law applied and that the act-of-state doctrine did not bar enforcement. On appeal, the United States Court of Appeals for the Second Circuit certified questions to the New York Court of Appeals, which held that Venezuelan law governs the validity of the notes.Upon remand, the district court concluded that the bond exchange did not violate Venezuelan law because only contracts executed by the Republic or its organs—not state-owned enterprises like PDVSA—are subject to the National Assembly approval requirement under Article 150. The district court also reaffirmed that the act-of-state doctrine did not apply due to the extraterritorial nature of the transaction. On further appeal, the United States Court of Appeals for the Second Circuit affirmed. The court held that National Assembly approval was not required, the governing documents were valid under Venezuelan law, and the act-of-state doctrine did not bar enforcement. View "leos v. MUFG" on Justia Law

The plaintiff was employed as a restaurant hostess by two corporate entities. She alleged that her supervisor engaged in sexual harassment and retaliation, resulting in her constructive discharge. She brought claims under California’s Fair Employment and Housing Act (FEHA) for gender discrimination, sexual harassment, retaliation, and failure to prevent discrimination, harassment, and retaliation. The plaintiff sought to hold the sole owner of the corporate entities personally liable, arguing he was their alter ego.A jury trial was held in the Superior Court of Los Angeles County on liability, which resulted in verdicts against the two corporate defendants and awarded the plaintiff compensatory and punitive damages. The alter ego claim against the owner was tried separately to the court. The trial court applied the common law presumption of corporate separateness, requiring the plaintiff to prove that the corporations’ distinct identities should be disregarded. The court found the plaintiff failed to meet her burden and issued judgment in favor of the owner. The plaintiff appealed, contending that FEHA should alter the presumption and favor alter ego liability.The Court of Appeal of the State of California, Second Appellate District, Division One, reviewed the legal question de novo. The court held that FEHA does not modify or abrogate the common law presumption of corporate separateness. It found no statutory language, legislative history, or case law that clearly or unequivocally indicated a legislative intent to alter the presumption. The court concluded that public policy and FEHA’s purpose do not require a contrary presumption favoring alter ego liability. The judgment for the owner was affirmed, and the parties were directed to bear their own costs on appeal. View "Villasenor v. Schneiter" on Justia Law

This case concerns a dispute among shareholders of Sinovac Biotech Ltd., a biopharmaceutical company incorporated in Antigua and Barbuda. MW Gestion, an investment management firm holding Sinovac securities, sued several other shareholders—including Jiaqiang Li, his company 1Globe Capital LLC, and related individuals—alleging tortious interference with contract and securities fraud. The central issue arose from a Rights Agreement adopted by Sinovac in 2016, which included a "poison pill" provision designed to prevent any single shareholder from acquiring excessive control without triggering dilution of their shares. MW Gestion claimed the defendants concealed the extent of their ownership to circumvent this provision and associated disclosure requirements, thereby harming other shareholders.Prior to this action, Sinovac and 1Globe had litigated related matters in the Delaware Court of Chancery, the U.S. District Court for the District of Massachusetts, and courts in Antigua, all contesting the validity of the Rights Agreement. In 2020, the U.S. Securities and Exchange Commission issued a cease-and-desist order against Li and 1Globe for violations of disclosure requirements. Following a series of stays and the invalidation of the Rights Agreement by the Privy Council in January 2025, the U.S. District Court for the District of Massachusetts denied MW Gestion’s motion to amend its complaint to add a tortious interference with business relations claim, finding MW Gestion had engaged in undue delay by waiting for the Privy Council’s decision.The United States Court of Appeals for the First Circuit reviewed whether the district court abused its discretion in denying leave to amend and whether dismissal of securities fraud claims as time-barred was correct. The First Circuit affirmed both rulings, holding that the district court did not abuse its discretion in finding undue delay and that MW Gestion’s securities fraud claims were untimely because MW Gestion knew or should have known of the facts underlying those claims by May 2020. View "MW Gestion v. 1Globe Capital LLC" on Justia Law

The United States Securities and Exchange Commission brought an enforcement action against a biotechnology company, its affiliates, and three principal officers. The company was developing an intravenous drug called RJX, which had not yet received FDA approval. The SEC alleged that the defendants engaged in securities fraud by making misleading statements to investors regarding the principals’ compensation, the existence of audited financial statements and the company’s readiness to go public, and the company’s involvement in litigation. The factual record at the preliminary injunction stage showed discrepancies between reported and actual compensation, false claims about audited statements and IPO readiness, and statements denying ongoing litigation despite a significant lawsuit and settlement.The United States District Court for the District of Colorado initially issued a temporary restraining order and asset freeze at the SEC’s request, then granted a preliminary injunction with an asset freeze after reviewing the parties’ written submissions. The district court allowed the defendants to request modifications to the asset freeze, and later partially lifted it to permit certain business activities, such as third-party payments and licensing of intellectual property. The court denied a motion to fully lift the freeze and declined to appoint a liquidation agent, finding the SEC adequately represented investor interests. The defendants appealed both the initial injunction and the refusal to fully lift the freeze.The United States Court of Appeals for the Tenth Circuit reviewed the district court’s orders for abuse of discretion and affirmed. The appellate court held that the district court was not required to hold an evidentiary hearing, since the defendants had requested cancellation and never sought to reschedule. It further held that the SEC made a strong showing on all four factors for a preliminary injunction, including likely success on the merits of securities fraud claims. The asset freeze, as modified, was found to be a reasonable means to preserve assets and protect investors. View "USSEC v. Reven Holdings" on Justia Law

The case centers on a longstanding family partnership, formed originally in 1988 and later converted to a limited partnership. Rick served as the managing partner, with other family members as partners. Following the death of a parent in 2011, annual financial meetings ceased, and several partners alleged they did not receive adequate financial records or updates for years. Concerns arose over Rick’s management, including incomplete and disorganized financial disclosures, and withdrawals from accounts over which Rick had power of attorney. These issues, along with disputed partnership interests and controversial financial transactions, led to Rick’s removal as managing partner and triggered litigation over his alleged breach of fiduciary duties.The District Court for Douglas County was presented with an amended complaint alleging Rick’s breach of fiduciary duties to the partnership. Rick moved to dismiss, arguing that a related county court proceeding involving a family trust precluded jurisdiction, but the district court denied the motion. Rick filed responses and counterclaims, but failed to properly plead affirmative defenses such as the statute of limitations. Extensive discovery and a bench trial followed, with evidence showing Rick’s negative capital account and numerous questionable withdrawals and transfers.The Nebraska Supreme Court reviewed the district court’s rulings de novo, including jurisdictional questions, evidentiary issues, and the award of attorney fees. The Court held that it had jurisdiction, affirmed the district court's findings that Rick no longer had an ownership interest in the partnership due to his negative capital account, and upheld the damages awarded for his breaches of fiduciary duty. The Court also affirmed the award of attorney fees to the prevailing parties and rejected Rick’s arguments regarding lack of specificity in pleadings, statute of limitations, and the district court’s jurisdiction. The district court’s orders were affirmed in full. View "Berkshire v. Berkshire" on Justia Law

This case arose from a conflict regarding the distribution of Kirkland Signature alcoholic beverages in Arkansas. Under Arkansas’s three-tier system for alcohol distribution, several manufacturers registered different Kirkland Signature products with the Arkansas Alcoholic Beverage Control (ABC) Division, designating different wholesalers. After realizing that multiple wholesalers were assigned to the same brand, the ABC Director directed all Kirkland Signature manufacturers to use the same wholesaler—Moon Distributors—because Moon was the first registered wholesaler for the brand. As a result, the Director granted change requests from two manufacturers (Mach Flynt and Levecke) that switched their designated wholesaler from Arkansas Wine and Spirits (AWS) to Moon Distributors, effectively removing AWS as a wholesaler for those Kirkland Signature products.After the Director’s decision, AWS appealed to the Arkansas Alcoholic Beverage Control Board (Board), which held a hearing and upheld the Director’s ruling. AWS then sought review in the Pulaski County Circuit Court, which affirmed the Board’s decision. AWS further appealed, and the Arkansas Court of Appeals certified the case to the Supreme Court of Arkansas, which accepted review.The Supreme Court of Arkansas held that, under Arkansas Code Annotated section 3-2-403, Kirkland Signature constitutes a single brand for distribution purposes, requiring all manufacturers of that brand to designate the same exclusive wholesaler. The court found the statute ambiguous but, after applying rules of statutory construction and reviewing relevant regulations, determined that the legislative intent was to grant wholesalers exclusivity for each brand. The court also held that the Board’s decision was supported by substantial evidence and was not arbitrary, capricious, or an abuse of discretion. Accordingly, the Supreme Court of Arkansas affirmed the Board’s decision. View "ARKANSAS WINE AND SPIRITS WHOLESALE, LLC v. ARKANSAS DEPARTMENT OF FINANCE AND ADMINISTRATION" on Justia Law

This dispute centers on the competitive conduct between United Therapeutics Corporation (UTC), the manufacturer of the brand-name drug Remodulin, and Sandoz, Inc. and its marketing partner RareGen, LLC, which sought to launch a generic version of treprostinil for treating pulmonary arterial hypertension. After Sandoz received FDA approval to market injectable generic treprostinil, UTC and Smiths Medical took steps to restrict the supply of cartridges necessary for subcutaneous administration, ultimately requiring specialty pharmacies to distribute cartridges exclusively for Remodulin. As a result, Sandoz was unable to launch its generic drug for subcutaneous use until an alternative cartridge was developed and FDA-approved several years later. Sandoz and RareGen alleged that UTC’s conduct violated federal antitrust and state tort laws and breached a settlement agreement arising from prior patent litigation.The U.S. District Court for the District of New Jersey dismissed the antitrust and state-law tort claims, granted summary judgment in favor of Sandoz as to liability on its breach-of-contract claim, and awarded damages after a bench trial. The court also denied UTC’s motion to exclude Sandoz’s damages expert. RareGen was dismissed from the case following the grant of summary judgment, and both UTC and Sandoz appealed various rulings.The United States Court of Appeals for the Third Circuit reversed the grant of summary judgment in favor of Sandoz on liability for the breach-of-contract claim, finding the relevant provisions ambiguous and remanding for trial. It also reversed the grant of summary judgment in favor of UTC on the tortious interference claim, instructing the District Court to analyze it independently from the antitrust claims. The Third Circuit affirmed the dismissal of the antitrust and unfair and deceptive trade practices claims, concluding that UTC demonstrated procompetitive justifications for its conduct. The appellate court affirmed the denial of UTC’s Daubert motion to exclude the damages expert, and vacated the damages award, remanding for further proceedings. View "Sandoz Inc v. United Therapeutics Corporation" on Justia Law

Investors in an e-commerce company alleged they were defrauded by the founder and former CEO, claiming that their decisions to purchase preferred shares in early 2021 were based on false representations about the company’s profitability and financial health. The founder repeatedly refused to provide audited financial statements before closing, and pressured the investors to move quickly, warning that their allocation would be lost to other parties if they delayed for due diligence. The investors relied on unaudited financial statements and entered into two stock purchase agreements in February and March 2021. After the transactions, the company failed to provide audited financial statements by the contractual deadline, and the founder sold significant personal stock. In June 2022, the investors finally received audited statements revealing substantial losses and inconsistencies with previous unaudited reports.The investors initially filed suit in New Jersey in August 2024. After enforcement of the Delaware forum-selection clause, they dismissed the New Jersey action and refiled in the Superior Court of the State of Delaware in April 2025, asserting claims for fraud, negligent misrepresentation, unjust enrichment, and a New Jersey statutory claim. The Superior Court dismissed the complaint, holding that the claims accrued no later than March 2021 and were barred by Delaware’s three-year statute of limitations. The court found no basis for tolling under fraudulent concealment or inherently unknowable injury doctrines, reasoning the investors were on inquiry notice when they executed the agreements without the requested information.On appeal, the Supreme Court of the State of Delaware reviewed the statute of limitations question de novo. The Court held that, regardless of tolling doctrines, inquiry notice was triggered in April 2021 when the company breached its obligation to provide audited financials. Because the investors filed more than three years later, their claims were time-barred. The Supreme Court affirmed the Superior Court’s dismissal. View "Cornice Ventures I LLC v. Silberstein" on Justia Law

The dispute centers on real property originally acquired by John and Constance Clark as part of a family farming operation. In 1988, two parcels were conveyed to their son, Jay Clark, who subsequently transferred the properties to Clover Hollow Farms, Inc., a corporation formed shortly before the conveyance with John Clark as its sole shareholder. Jay Clark served as vice-president and director of Clover Hollow. According to Jay Clark, his parents promised that Clover Hollow would hold the property in trust for him as a premarital asset, to be returned upon demand or subject to his exclusive control. Years later, Jay Clark assigned his interests in one of the properties to C & H Properties, LLC, operated by his children.After John Clark was placed under a conservatorship, the conservator, Judith Appleby, adopted corporate resolutions nullifying Jay Clark’s authority and authorizing the corporation to join litigation seeking a declaration that Jay Clark had no interest in the corporate stock, real property, or tangible property. Jay Clark filed counterclaims challenging the validity of these resolutions and seeking to regain title to the properties. The District Court of the Third Judicial District, Canyon County, granted summary judgment to the Estates and Clover Hollow. It ruled that judicial estoppel barred Jay Clark’s claims due to his failure to disclose the properties in bankruptcy and found that his claims under constructive trust, promissory estoppel, and unjust enrichment failed as a matter of law. The court also upheld the corporate resolutions enacted by Appleby.The Supreme Court of the State of Idaho reviewed the district court’s rulings. It held that Ms. Appleby, as executor, lacked authority under Clover Hollow’s bylaws and the Idaho Business Corporation Act to convene a special shareholder meeting and enact corporate resolutions, rendering those actions invalid. Consequently, Clover Hollow was never properly joined in the litigation. The Supreme Court vacated the judgment, reversed the grant of summary judgment on Jay Clark’s sixth counterclaim, and remanded the case with instructions to allow reasonable time for proper joinder of Clover Hollow as a party. View "Estate of Clark v. Clark" on Justia Law